While off-label use may be permissible, contraindicated use still has a strong regulatory boundary as reinforced by FDA guidance finalized in 2025.
A recent survey of 2,000 UK patients found one in four patients (24%) already use AI for health guidance, and nearly one in ...
In the current Cyber Threat environment, companies must have strong cyber liability insurance. Policies must specifically account for cyber-physical risks and the substantial costs of post-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback